IP Library Granted Patent US 7,803,577
Granted Patent B2
US 7,803,577 · App. 11/880,320 · Granted Sep 28, 2010

Tropoelastin derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,803,577
App. No.
11/880,320
Granted
Sep 28, 2010
Kind
B2
Abstract

The invention relates to derivatives of tropoelastin and variants of those derivatives. The invention further provides expression products and hybrid molecules of the derivatives and variants of the invention. The invention further provides methods for the production of the derivatives, variants, expression products and hybrid molecules. Further provided are formulations, cross-linked structures and implants comprising the derivatives, variants, expression products and hybrid molecules of the invention. Further provided are uses of the derivatives, variants, expression products and hybrid molecules of the invention.

Claims (12)

1. An isolated polynucleotide encoding a tropoelastin polypeptide wherein the polynucleotide has one or more of the following sequences:

(a) the nucleotide sequence from position 9 to position 1676 of SEQ ID NO:1 contiguous with position 1776 to 2201 of SEQ ID NO:1;

(b) the nucleotide sequence from position 1554 to 1676 of SEQ ID NO: 1 contiguous with 1776 to 2201 of SEQ ID NO: 1; and

(c) the nucleotide sequence from position 1663 to 1676 contiguous with 1776 to 1791 of SEQ ID NO: 1.

2. An expression vector comprising the polynucleotide of claim 1 .

3. An isolated cell transformed with the vector of claim 2 .

4. A method for producing a tropoelastin polypeptide, comprising:

introducing the vector of claim 2 into a suitable host cell, and maintaining the cell under conditions suitable for expression of the tropoelastin polypeptide.

5. The polynucleotide of claim 1 comprising:

the nucleotide sequence from position 9 to position 1676 of SEQ ID NO: 1 contiguous with position 1776 to 2201 of SEQ ID NO: 1.

6. The polynucleotide of claim 1 having the nucleotide sequence from position 1554 to 1676 of SEQ ID NO: 1 contiguous with position 1776 to 2201 of SEQ ID NO: 1.

7. The polynucleotide of claim 1 having the nucleotide sequence from position 1663 to 1676 contiguous with position 1776 to 1791 of SEQ ID NO: 1.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: ELASTAGEN PTY LTD
To: ALLERGAN AUSTRALIA PTY LTD
Reel/Frame 048163/0642 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: ALLERGAN AUSTRALIA PTY LTD
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 048164/0458 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2017
From: THE UNIVERSITY OF SYDNEY
To: ELASTAGEN PTY LTD
Reel/Frame 042994/0327 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2010
From: WEISS, ANTHONY S.
To: SYDNEY, UNIVERSITY OF
Reel/Frame 024760/0935 →